Effect of angiotensin converting enzyme inhibitors, on quality of life in hypertensive patients. Pharmacodynamic basis

Fundamental and Clinical Pharmacology

Volumn 10, Issue 4, 1996, Pages 400-405

  Govantes, C ^a   Marin J ^a,b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Angiotensin converting enzyme inhibitors; Central nervous system; Cerebral autoregulation; Hypertension; Quality of life

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; ATENOLOL; BRADYKININ; CAPTOPRIL; CILAZAPRIL; CORTICOTROPIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDORPHIN; ENKEPHALIN; EXCITATORY AMINO ACID; FREE RADICAL; LISINOPRIL; METHYLDOPA; NITRENDIPINE; NITRIC OXIDE; NORADRENALIN; PROPRANOLOL; VASOPRESSIN;

ARTICLE; BRAIN BLOOD FLOW; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CLINICAL TRIAL; COGNITION; DRUG MECHANISM; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; MEMORY; PRIORITY JOURNAL; QUALITY OF LIFE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0029741336     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1996.tb00592.x     Document Type: Article

References (61)

1. Agnati LF, Fuxe K, Giardino L et al. Evidence for cholecystokinin-dopamine receptor interactions in the central nervous system of the adult and old rat. Studies on their functional meaning. Ann NY Acad Sci 1985;448:315-33
2. Agullo L, García A. Different receptors mediate stimulation of nitric oxide-dependent cyclic GMP formation in neurons and astrocytes in culture. Biochem Biophys Res Commun 1993;182:1363-8
3. Aihara K. Effects of nitrendipine on the autoregulation of regional blood flow in the pithed rabbit. Naunyn Schmiedebergs Arch Pharmacol 1989;334:469-73
4. Applegate WB, Phlipps HL, Schnaper H et al. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 1991;151:1817-23
5. Barnes JM, Barnes NM, Costall B et al. Angiotensin-converting enzyme inhibition, angiotensin, and cognition. J Cardiovase Pharmacol 1992;19(suppl 6):S63-71
6. Barnes JM, Barnes NM, Costall B et al. Angiotensin II inhibits cortical cholinergic function: implications for cognition. J Cardiovasc Pharmacol 1990;16:234-8
7. Barnes JM, Steward LJ, Barber PC, Barnes NM. Identification and characterization of angiotensin II receptor subtypes in human brain. Eur J Pharmacol 1993;230:251-8
8. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217:408-17
9. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1-80
10. Bulpitt JC, Fletcher AE. Cognitive function and angiotensin-converting enzyme inhibitors in comparison with other anti-hypertensive drugs. J Cardiovasc Pharmacol 1992;19(suppl 6):S100-4
11. Bunnemann B, Fuxe K, Ganten D. The renin-angiotensin system in the brain: an update. Regul Pept 1993;46: 487-509
12. Cachofiero V, Guan H, Nasjletti A. Mecanismos de acción de los inhibidores de la ECA: nuevas perspectivas. Hipertensión 1993;10(suppl 1):27-31
13. Chai SY, Johnston CI. Tissue distribution of angiotensin-converting enzyme. In: Laragh JH, Brenner BM, eds. Hypertension. Pathophysiology, Diagnosis and Management. New York: Raven Press, Ltd, 1995:1683-93
14. Costall B, Domeney AM, Gerrard PA et al. The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition. Pharmacol Biochem Behav 1990;36:13-20
15. Croog SB, Levine S, Testa M et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314:1657-64
16. Chen BZ, Mendelsohn FAO. Effect of acute and chronic administration of ceronapril on angiotensin converting enzyme in plasma, kidney, lung, brain regions and cerebrospinal fluid of rats. Neuropharmacology 1992;31:929-35
17. Chen L, Re RN, Prakash O, Mondal D. Angiotensin-converting enzyme inhibition reduces neuroblastoma cell growth rate. Proc Soc Exp Biol Med 1991;196:280-3
18. Dantzer R, Bluthé RM. Vasopressin and behavior: from memory to olfaction. Regul Pept 1993;45:121-5
19. Démolis P, Carville C, Giudicelli JF. Effects of an angiotensin-converting enzyme inhibitor, Lisinopril, on cerebral blood flow autoregulation in healthy volunteers. J Cardiovasc Pharmacol 1993;22:373-80
20. Deicken RF. Captopril treatment of depression. Biol Psychiatr 1986;21:1425-8
21. Dimsdale JE. Reflections on the impact of antihypertensive medications on mood, sedation, and neuropsychologic functioning. Arch Intern Med 1992;152:35-9
22. Etienne PE, Zubensko GS. Does captopril elevate mood? Trends Pharmacol Sci 1987;8:329-40
23. Faraci FM, Baumbach GL, Hesstad DD. Myogenic mechanisms in the cerebral circulation. J Hypertens 1989;7 (suppl):S61-4
24. Ferrario CM. The renin-angiotensin system: importance in physiology and pathology. J Cardiovasc Pharmacol 1990;15(suppl 3):S1-5
25. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991;14:60-7
26. Gillis N, Chen X, Merker MM. Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury. J Pharmacol Exp Ther 1992; 262:212-6
27. Handa K, Sasaki J, Tanaka H et al. Effects of captopril on opioid peptides during exercise and quality of life in normal subjects. Am Heart J 1991;122:1389-94
28. Hjemdahl P, Wiklund IK. Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? J Hypertens 1992;10:1437-46
29. Hock FJ, Wiemer G. Involvement of nitric oxide formation in the action of ramipril and ramipril-octil in an inhibitory avoidance task in mice. Drug Dev Res 1991;27:229-37
30. Hock FJ, Wirth K, Albus U et al. Hoe 140, a new potent and long acting bradykinin antagonist: in vitro studies. Br J Pharmacol 1991;102:769-73
31. Hökfelt T, Skirboll I, Rehfeld JF, Goldstein M, Markey K, Dann O. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from inmunochemistry combine with retrograde tracing. Neuroscience 1980;5:2093-124
32. Hölscher C, Rose SPR. Inhibiting synthesis of the putative retrograde messenger nitric oxide results in amnesia in a passive avoidance task in the chick. Brain Res 1993; 619:189-94
33. Kiowski W, Linder L, Kleinbloesem C, Van Brummelen P, Bühler FR. Blood pressure control by the renin-angiotensin system in normotensive subjects. Circulation 1992;85:1-8
34. Lancaster JR. Nitric oxide in cells. Am Scient 1992;80:248-59
35. Legros JJ, Ansseau M, Timsit-Berthier M. Neurohypophyseal peptides and psychiatric diseases. Regul Pept 1993; 45:133-8
36. Leonetti G, Salverti A. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an italian multicentric study. J Cardiovasc Pharmacol 1994;24(suppl 3):S73-7
37. Levy BI, Sajar ME. Remodelling of the vascular system in response to hypertension and drug therapy. Clin Exp Pharmacol Physiol 1992;19(suppl):33-7
38. Lewis RV, Lofthouse C. Adverse reactions with beta-adrenoceptor blocking drugs. An update. Drug Saf 1993;9:272-9
39. 2+ in mammalian neurons. Trends Pharmacol Sci 1990;11:254-60
40. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42
41. Mondadori C, Hengerer B, Ducret T, Borkowski J. Delayed emergence of effects of memory-enhancing drugs: implications for the dynamics of long-term memory. Proc Natl Acad Sci USA 1994;91:2041-5
42. Paulson OB, Waldemar G. Role of the local renin-angiotensin system in the autorregulation of the cerebral circulation. Blood Vessels 1991;28:231-5
43. Phillips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 1993;43:1-20
44. Rubanyi GM, Johns A, Wilcox D, Bates FN, Harrison D. Evidence that a S-nitrosothiol, but not nitric oxide, may be identical with endothelium-derived relaxing factor. J Cardiovasc Pharmacol 1991;17:S41-5
45. Sadoshima S, Nagar T, Ibayashi J, Fujishima M. Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertension rats. Hypertension 1994;23:781-5
46. Schrör K. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1992;20(suppl 9):S68-73
47. Schwartz JC, Malfroy B, La Baume SD. Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxipeptidase ('enkephalinase') as neuropeptidase. Life Sci 1981;29:1715-40
48. Sharma SH. Effect of captopril (a converting enzyme inhibitor) on blood-brain barrier permeability and cerebral blood flow in normotensive rats. Neuropharmacology 1987;26:85-92
49. Silber M, Almkuist O, Larsson B, Uunas-Moberg K. Temporary peripartal impairment in memory and attention and its possible relations to oxytocin concentration. Life Sci 1990; 47:57-65
50. 3H]dopamine in rat striatal slices. Neurosci Lett 1979;15:153
51. Smith WT, Glaudin V, Cohen J, Sudilovsky A. A pilot study of SQ29,852 in patients with generalised anxiety disorder (GAD). Proceedings of the 17th Congress of Collegium Internationale Neuro-Psychopharmacologicum, Kyoti, Japan, September 10-14, 1990:Abstract p12-1-12
52. Song K, Allen AM, Paxinos G, Mendelsohn FAO. Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J Compar Neurol 1992;316:467-84
53. Strandgaard S, Paulson OB. Regulation of cerebral blood flow in health and disease. J Cardiovasc Pharmacol 1992;19 (suppl 6):S89-93
54. Sudilovsky A, Turnbull BA, Miller LH, Traficante LJ. Attenuation of apomorphine induced sterotypy by captopril pretreatmem. Soc Neurosci Abstr 1983;9:132
55. Testa MA, Anderson RB, Nackley JF, Hollenberg NK. Quality of life and hypertensive therapy in men. A comparison of captopril with enalapril. N Engl J Med 1993;328:907-13
56. Thind GS. Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics. Cardiovasc Drugs Ther 1990;4:199-206
57. Unger T, Bao G, Gohlke P. Posible papel de las quininas inducidas por un inhibidor de la ECA sobre la reducción de la presión sanguínea y la proliferación capilar en el miocardio de ratas hipertensas. Hipertensión 1993;10(suppl 1):15-8
58. Vrobel TR. Psychiatrie aspects of congestive heart failure: implications for consulting psychiatrists. Int J Psychiatr Med 1989;19:211-25
59. Weiner I, Smith AD, Pawlins JNP, Feldon J. A neuroleptic-like effect of ceronapril on latent inhibition. Neuroscience 1992;49:307-15
60. Werner C, Hoffman WE, Kochs E, Rabito SF, Miletich DJ. Captopril improves neurologic outcome from incomplete cerebral ischemia in rats. Stroke 1991;22:910-4
61. Zubensko GS, Nixon RA. Mood-elevating effect of captopril in depressed patients. Am J Psychiatr 1984;141:110-11